SFX by Ex Libris Inc.

Title:	Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies
Source:	Blood [0006-4971] Rezvani, Katayoun yr:2008

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Scheibenbogen, C. "CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia." Blood 100.6 (2002): 2132-7.
description	2.	Butt, Nauman M M. "BCR-ABL-specific T cells can be detected in healthy donors and in chronic myeloid leukemia patients following allogeneic stem cell transplantation." Blood 103.8 (2004): 3245-.
description	3.	Van Tendeloo, Viggo F. "Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination." Proceedings of the National Academy of Sciences of the United States of America 107.31 (2010): 13824-13829.
description	4.	Yasukawa, M. "Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome." American journal of hematology (2009): 314-315.
description	5.	Dolstra, H. "A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia." The Journal of experimental medicine 189.2 (1998): 301-8.
description	6.	Dolstra, H. "Bi‐directional allelic recognition of the human minor histocompatibility antigen HB‐1 by cytotoxic T lymphocytes." European Journal of Immunology 32 (2002): 2748-58.
description	7.	June, Carl H. "Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia." The New England journal of medicine 365.8 (2011): 725-733.
description	8.	Borrello, Ivan M. "Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)." Blood 114.9 (2009): 1736-45.
description	9.	Gripp, S. "Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth?" Cancer 116.13 (2010): 3251-3256.
description	10.	Zakhaleva, V. "Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia." Blood 116.2 (2010): 171-179.
description	11.	Xue, S. "Development of a Wilms' tumor antigen-specific T-cell receptor for clinical trials: engineered patient's T cells can eliminate autologous leukemia blasts in NOD/SCID mice." Haematologica 95.1 (2010): 126-134.
description	12.	Gannage M, M. "Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive cellular immunotherapy." The journal of immunology 174.12 (2005): 8210-8.
description	13.	Van Driessche, A. "Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial." Cytotherapy 11.5 (2009): 653-16.
description	14.	den Haan, J M M. "The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism." Science 279.5353 (1998): 1054-7.
description	15.	Kugler, A. "Regression of human metastatic renal cell carcinoma after vaccination with tumor cell− dendritic cell hybrids." Nature medicine 6.3 (2000): 332-336.
description	16.	Lowdell, W. "Immunotherapy of AML: future directions." Journal of clinical pathology (2000): 49-.
description	17.	Schirle, M. "Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach." European journal of immunology 30.8 (2000): 2216-25.
description	18.	Rosenberg, Steven A. "A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response." Clinical cancer research 21.5 (2014): 1019-1027.
description	19.	Kalos, M. "T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia." Science translational medicine 3.95 (2011): 95-95.
description	20.	Brentjens, Renier J. "CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia." Science translational medicine 5.177 (2013): 177-177.